SBC Medical Group Holdings Inc., a Japanese owner and operator of aesthetic medical clinics, has completed a strategic investment in OrangeTwist, a U.S.-based medspa chain, marking its official entry into the American market. The partnership enables SBC to leverage OrangeTwist's 24 locations across six states and its advanced management system integrating procurement, clinical workflows, and real-time KPI tracking. This move comes as the medical aesthetics industry is forecast to grow from $34 billion today to $48 billion by 2030, driven by demand for non-surgical treatments with minimal risk and downtime.
The aging U.S. population is increasing demand for non-invasive aesthetic treatments, creating opportunities for expansion. SBC plans to help OrangeTwist address "white space" in the market—cities with high demand but few competitors—by combining resources to establish first-mover advantages. Stephen Rodgers, global head of planning and strategy at SBC Medical, stated in an interview with Benzinga that the company seeks local partnerships rather than replicating its Japanese model exactly. Beyond joint clinic operations, the companies plan to develop branded products and sell existing products in each other's spas.
SBC's expansion strategy extends beyond medical aesthetics into the broader longevity industry, which is shifting from increasing lifespan to boosting "healthspan" through personalized, preventative solutions. According to Gabelli Research, the global anti-aging market, valued at approximately $85 billion in 2025, is expected to surpass $120 billion by 2030, with North America accounting for about 30% of the market. SBC believes its existing infrastructure positions it to offer AI-powered diagnostics, GLP-1 weight-loss drugs, and regenerative therapies like stem cells.
While the OrangeTwist partnership provides a U.S. foothold, SBC continues expanding in Japan and Southeast Asia by applying its proven business model to help clinics with staff training, medical equipment pricing, and management services. The company's global strategy focuses on partnering with high-performing regional operators, deploying expertise to drive efficiencies, and securing first-mover advantages. By standardizing services across markets, SBC aims to ensure consistent quality and pricing for patients, implementing this approach in Japan, Thailand, and Singapore.
SBC Medical, which already manages 258 affiliated clinics worldwide and over six million patient visits annually, is building a global network through replicable partnerships. The company's collaboration with OrangeTwist demonstrates how sharing successful approaches with local providers can create a trusted brand for aesthetic beauty services worldwide, capitalizing on growing demand in both U.S. and Asian markets where customers prefer natural-looking treatments with minimal recovery times.
